Christian Kanstrup
Patrimonio netto: 65 619 $ in data 31/05/2026
Patrimonio netto: 65 619 $ in data 31/05/2026
Christian Kanstrup is currently Chief Executive Officer at CKC ApS and Mr. Kanstrup Holding ApS, Chairman at Mediq Holding Danmark ApS, Independent Director at NNIT A since 2018, Director at Novo Nordisk Haemophilia Foundation, and Independent Director at Sleep Cycle AB starting in 2025.
Former roles include Chief Executive Officer at Evaxion AS from 2023 to 2025, Director at FastPassCorp A in 2019, Director at Glycom A, and SVP-Strategy, Access & Marketing at Novo Nordisk A from 2016 to 2017.
Education includes graduate degrees from the University of Copenhagen and the International Institute for Management Development.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
SLEEP CYCLE AB 0,09% | 12/03/2026 | 17.500 ( 0,09% ) | 46 530 $ | 31/05/2026 |
NNIT A/S 0,01% | 31/12/2025 | 3.000 ( 0,01% ) | 19 089 $ | 31/05/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| NNIT A/S | Direttore/Membro del Consiglio | 08/03/2018 |
| SLEEP CYCLE AB | Direttore/Membro del Consiglio | 28/10/2025 |
Novo Nordisk Haemophilia Foundation | Direttore/Membro del Consiglio | - |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Presidente | - |
Christian Kanstrup Holding ApS | Amministratore Delegato | - |
CKC ApS | Amministratore Delegato | - |
| Società | Posizione | Fine |
|---|---|---|
| EVAXION A/S | Amministratore Delegato | 01/07/2025 |
| FASTPASSCORP A/S | Direttore/Membro del Consiglio | 02/03/2019 |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Direttore/Membro del Consiglio | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 12 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
FastPassCorp A/S
FastPassCorp A/S Information Technology ServicesTechnology Services Provides password management solutions, account unlock, and mapping services | Technology Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
NNIT A/S
NNIT A/S Information Technology ServicesTechnology Services Provides digital transformation solutions to international life sciences companies | Technology Services |
Novo Nordisk Haemophilia Foundation | |
Evaxion Biotech A/S
Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
CKC ApS | |
Christian Kanstrup Holding ApS | |
Sleep Cycle AB
Sleep Cycle AB Packaged SoftwareTechnology Services Develops sleep applications and tools for tracking and analyzing sleep habits | Technology Services |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale